Loading insider details...
Beta
Latest Form 4 (Jun 26, 2026): Grant/Award of 31,746 NAGE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 26, 2026 | Niagen Bioscience, Inc. (NAGE) | Grant/Award | 31,746 | n/a |
| Jun 26, 2025 | Niagen Bioscience, Inc. (NAGE) | Grant/Award | 20,000 | n/a |
| Dec 14, 2024 | ChromaDex Corp. (CDXC) | Exercise/Conversion | 50,001 | $183.0K |
| Jun 21, 2024 | ChromaDex Corp. (CDXC) | Grant/Award | 20,000 | n/a |
| Jun 16, 2023 | ChromaDex Corp. (CDXC) | Grant/Award | 20,000 | n/a |
| Jun 13, 2023 | ChromaDex Corp. (CDXC) | Purchase | 7,000 | $11.8K |
| Feb 22, 2022 | ChromaDex Corp. (CDXC) | Grant/Award | 107,805 | n/a |
| Mar 17, 2021 | ChromaDex Corp. (CDXC) | Grant/Award | 25,072 | n/a |
| Dec 11, 2020 | ChromaDex Corp. (CDXC) | Exercise/Conversion | 41,667 | $192.5K |
| Feb 28, 2020 | ChromaDex Corp. (CDXC) | Grant/Award | 74,048 | n/a |